Level Four Advisory Services LLC Decreases Stock Holdings in STERIS plc (NYSE:STE)

Level Four Advisory Services LLC lowered its stake in shares of STERIS plc (NYSE:STE) by 2.2% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,454 shares of the medical equipment provider’s stock after selling 56 shares during the quarter. Level Four Advisory Services LLC’s holdings in STERIS were worth $504,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Magnolia Capital Advisors LLC grew its position in shares of STERIS by 1.9% during the 4th quarter. Magnolia Capital Advisors LLC now owns 2,534 shares of the medical equipment provider’s stock valued at $521,000 after acquiring an additional 48 shares during the period. SkyView Investment Advisors LLC grew its holdings in STERIS by 1.6% during the third quarter. SkyView Investment Advisors LLC now owns 3,153 shares of the medical equipment provider’s stock valued at $765,000 after purchasing an additional 51 shares during the period. Park Edge Advisors LLC increased its position in STERIS by 1.1% in the fourth quarter. Park Edge Advisors LLC now owns 4,662 shares of the medical equipment provider’s stock worth $958,000 after buying an additional 51 shares during the last quarter. Citizens Financial Group Inc. RI raised its stake in shares of STERIS by 5.9% in the fourth quarter. Citizens Financial Group Inc. RI now owns 975 shares of the medical equipment provider’s stock valued at $201,000 after buying an additional 54 shares during the period. Finally, Opal Wealth Advisors LLC grew its stake in shares of STERIS by 5.7% during the 4th quarter. Opal Wealth Advisors LLC now owns 1,118 shares of the medical equipment provider’s stock worth $230,000 after acquiring an additional 60 shares during the period. Hedge funds and other institutional investors own 94.69% of the company’s stock.

STERIS Price Performance

STE stock opened at $227.14 on Tuesday. The firm has a 50 day simple moving average of $222.86 and a two-hundred day simple moving average of $221.01. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.40. The stock has a market cap of $22.32 billion, a PE ratio of 48.22 and a beta of 0.92. STERIS plc has a one year low of $197.82 and a one year high of $248.24.

STERIS (NYSE:STE) last released its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. On average, analysts predict that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Thursday, February 20th were given a $0.57 dividend. The ex-dividend date of this dividend was Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a yield of 1.00%. STERIS’s payout ratio is 48.41%.

Wall Street Analyst Weigh In

STE has been the subject of several recent research reports. Piper Sandler lifted their target price on shares of STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a research note on Monday, February 3rd. JMP Securities reiterated a “market outperform” rating and issued a $265.00 price objective on shares of STERIS in a research note on Thursday, February 6th. Finally, Stephens reaffirmed an “overweight” rating and issued a $240.00 price target on shares of STERIS in a report on Thursday, February 6th. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $258.75.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.